Home › Blood Cancers › Texas
Blood Cancers clinical trials in Texas
49 studies for Blood Cancers are looking for participants at sites in Texas.
Cities in Texas
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
- MD Anderson Cancer Center - University of Texas, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07572006Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- UT Southwestern-Harold C. Simmons Cancer Center ( Site 2730), Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04728893Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
- M D Anderson Cancer Center, Houston
RecruitingEarly phase 1
Ages 12 to 80 · All sexes · Updated Sep 23, 2026 · NCT04744116Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 6, Houston
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Sep 23, 2026 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
- UT MD Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT07743476Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Texas Oncology - Central/South Texas ( Site 8001), Austin
- Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas
- University of Texas MD Anderson Cancer Center ( Site 0007), Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT03486873Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- The Don and Sybil Harrington Cancer Center, Amarillo
- Audie L Murphy VA Hospital, San Antonio
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
- Texas Children's Hospital, Houston
- The Methodist Hospital, Houston
RecruitingPhase 1
Up to age 75 · All sexes · Updated Sep 16, 2026 · NCT06345027A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Md Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- M D Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02464696Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- M D Anderson Cancer Center, Houston
RecruitingPhase 2Healthy volunteers welcome
All ages · All sexes · Updated Sep 14, 2026 · NCT04984551Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
- M D Anderson Cancer Center, Houston
RecruitingPhase 1
All ages · All sexes · Updated Sep 4, 2026 · NCT03425526Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Baylor Scott & White Health, Dallas
- MD Anderson, Houston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- M D Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Aug 21, 2026 · NCT01772771Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
- M D Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05110742Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Texas Oncology-Austin Midtown, Austin
- Texas Oncology-Presbyterian Cancer Center, Dallas
- University of Texas, Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
- M D Anderson Cancer Center, Houston
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06184321Expressive Writing for the Management of Stress in Cancer Survivors
- M D Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT04776941A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- MD Anderson Cancer Center, Houston
- NEXT Oncology, Irving
- UT San Antonio Mays Cancer, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06823167The Impact of COVID-19 on Pulmonary Procedures
- M D Anderson Cancer Center, Houston
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 10, 2026 · NCT05022446Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies
- M D Anderson Cancer Center, Houston
RecruitingObservational study
All ages · All sexes · Updated Aug 10, 2026 · NCT05108519PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
- University of Texas MD Anderson MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT06665100A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- The University of TX MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07424833Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
- M D Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 16, 2026 · NCT04712539A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Medical City Dallas, Dallas
- Children's Medical Center Dallas, Dallas
- Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
- and 5 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Improving Comprehensive Care of Cancer Patients
- Baylor College of Medicine, Houston
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT05323409Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT02074839Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT00991094Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Jun 4, 2026 · NCT06131801The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 to 39 · All sexes · Updated Jun 2, 2026 · NCT04551378Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
- M D Anderson Cancer Center, Houston
RecruitingObservational studyHealthy volunteers welcome
Ages 21 and older · All sexes · Updated May 26, 2026 · NCT05054413Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT05011045Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 13 and older · All sexes · Updated May 5, 2026 · NCT04771572A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- and 1 more
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
- M D Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT05529069From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.